Boston Scientific Corporation (VIE:BSXC)

Boston Scientific Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 5, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Cap	91,286	121,664	113,321	72,862	57,062	52,073
Market Cap Growth	-38.56%	7.36%	55.53%	27.69%	9.58%	18.84%
Enterprise Value	100,120	130,019	122,411	80,163	63,952	58,217
PE Ratio	36.98	49.15	71.46	54.03	102.82	59.00
Forward PE	20.40	28.71	33.08	26.76	24.51	23.73
PEG Ratio	-	1.65	2.42	2.19	2.30	1.64
PS Ratio	5.34	7.04	7.86	5.95	5.23	5.09
PB Ratio	4.38	5.84	6.05	4.39	3.77	3.64
P/TBV Ratio	3.82	5.88	6.10	4.39	3.79	3.69
P/FCF Ratio	29.30	38.66	49.79	47.26	70.70	45.99
P/OCF Ratio	23.64	31.19	38.34	33.83	43.46	32.36
EV/Sales Ratio	5.78	7.53	8.50	6.54	5.86	5.69
EV/EBITDA Ratio	21.28	30.34	36.74	26.33	26.69	29.52
EV/EBIT Ratio	29.24	41.83	54.66	39.76	45.07	56.43
EV/FCF Ratio	32.14	41.31	53.79	51.99	79.24	51.41
Debt / Equity Ratio	0.47	0.47	0.49	0.47	0.51	0.55
Debt / EBITDA Ratio	2.30	2.30	2.78	2.57	3.21	3.96
Debt / FCF Ratio	3.13	3.13	4.06	5.08	9.53	6.89
Net Debt / Equity Ratio	0.39	0.39	0.48	0.43	0.46	0.43
Net Debt / EBITDA Ratio	1.90	1.90	2.67	2.33	2.88	3.12
Net Debt / FCF Ratio	2.59	2.59	3.91	4.60	8.54	5.43
Asset Turnover	0.48	0.48	0.45	0.42	0.39	0.38
Inventory Turnover	2.16	2.16	1.99	2.00	2.28	2.51
Quick Ratio	0.90	0.90	0.46	0.63	0.76	0.87
Current Ratio	1.62	1.62	1.08	1.32	1.51	1.48
Return on Equity (ROE)	12.45%	12.45%	8.89%	8.58%	4.08%	6.51%
Return on Assets (ROA)	7.43%	7.43%	5.65%	5.56%	3.12%	3.68%
Return on Invested Capital (ROIC)	8.50%	8.50%	6.39%	6.35%	3.63%	4.34%
Return on Capital Employed (ROCE)	10.14%	10.14%	8.24%	7.96%	5.82%	4.36%
Earnings Yield	2.70%	2.03%	1.40%	1.85%	0.97%	1.69%
FCF Yield	3.41%	2.59%	2.01%	2.12%	1.41%	2.17%
Buyback Yield / Dilution	-0.29%	-0.11%	-0.11%	-0.15%	-0.13%	-0.10%

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.